Emulsified isoflurane treatment inhibits the cell cycle and respiration of human bronchial epithelial 16HBE cells in a p53-independent manner

Yang,Hui; Deng,Jia; Jiang,Yingying; Chen,Jiao; Zeng,Xianzheng; He,Zhiyang; Jiang,Xiaojuan; Li,Zhuoning; Jiang,Chunling

doi:10.3892/mmr.2016.5257

Emulsified isoflurane treatment inhibits the cell cycle and respiration of human bronchial epithelial 16HBE cells in a p53-independent manner

Authors:
- Hui Yang
- Jia Deng
- Yingying Jiang
- Jiao Chen
- Xianzheng Zeng
- Zhiyang He
- Xiaojuan Jiang
- Zhuoning Li
- Chunling Jiang
View Affiliations

Affiliations: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Anesthesiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China
Published online on: May 12, 2016 https://doi.org/10.3892/mmr.2016.5257
Pages: 349-354

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Emulsified isoflurane (EIso), as a result of its rapid anesthetic induction, recovery and convenience, is widely used as a novel intravenous general anesthetic. Treatment with EIso can reduce injuries caused by ischemia/reperfusion (I/R) to organs, including the heart, lung and liver, without knowing understanding the molecular mechanism. The present study hypothesized that treatment with EIso can affect the physiological processes of human lung bronchial epithelial cells (16HBE) prior to I/R. To test this hypothesis, the present study first constructed stable p53 knockdown and synthesis of cytochrome c oxidase (SCO)2 knockdown 16HBE cells. The above cells were subsequently treated with EIso at a concentration of 0.1 and 0.2% for 24 h. The relevant concentration of fat emulsion was used as a negative control. The expression levels of p53, p21, SCO1, SCO2 and Tp53‑induced glycolysis and apoptosis regulator (TIGAR) were detected by reverse transcription‑quantitative polymerase chain reaction and western blotting. Subsequently, the cell proliferation, respiration and glycolysis were investigated. The results revealed that EIso treatment significantly decreased the transcription of TIGAR, SCO1 and SCO2, and increased the transcription of p21, which are all p53 target genes, in a p53-independent manner. The cell cycle was inhibited by arresting cells at the G0/G1 phase. Respiration was reduced, which caused a decrease in oxygen consumption and the accumulation of lactate and reactive oxygen species. Taken together, EIso treatment inhibited the proliferation and respiration, and promoted glycolysis in 16HBE cells. This regulatory pathway may represent a protective mechanism of EIso treatment by inhibiting cell growth and decreasing the oxygen consumption from I/R.

View Figures

View References

1	Lucchinetti E, Schaub MC and Zaugg M: Emulsified intravenous versus evaporated inhaled isoflurane for heart protection: Old wine in a new bottle or true innovation? Anesth Analg. 106:1346–1349. 2008. View Article : Google Scholar : PubMed/NCBI
2	Hu ZY and Liu J: Effects of emulsified isoflurane on haemodynamics and cardiomyocyte apoptosis in rats with myocardial ischaemia. Clin Exp Pharmacol Physiol. 36:776–783. 2009. View Article : Google Scholar : PubMed/NCBI
3	Kersten JR, Schmeling TJ, Pagel PS, Gross GJ and Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K (ATP) channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 87:361–370. 1997. View Article : Google Scholar : PubMed/NCBI
4	Rao Y, Wang YL, Zhang WS and Liu J: Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits. Anesth Analg. 106:1353–1359. 2008. View Article : Google Scholar : PubMed/NCBI
5	Murry CE, Jennings RB and Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
6	Schurr A, Reid KH, Tseng MT, West C and Rigor BM: Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res. 374:244–248. 1986. View Article : Google Scholar : PubMed/NCBI
7	Lv X, Wang ZM, Huang SD, Song SH, Wu FX and Yu WF: Emulsified isoflurane preconditioning reduces lung injury induced by hepatic ischemia/reperfusion in rats. Int J Med Sci. 8:353–361. 2011. View Article : Google Scholar : PubMed/NCBI
8	Hu ZY, Abbott GW, Fang YD, Huang YS and Liu J: Emulsified isoflurane postconditioning produces cardioprotection against myocardial ischemia-reperfusion injury in rats. J Physiol Sci. 63:251–261. 2013. View Article : Google Scholar : PubMed/NCBI
9	Hu ZY, Peng XY, Liu F and Liu J: Emulsified isoflurane protects rat heart in situ after regional ischemia and reperfusion. Fundam Clin Pharmacol. 28:190–198. 2014. View Article : Google Scholar
10	Di Lisa F and Bernardi P: Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole. Cardiovasc Res. 70:191–199. 2006. View Article : Google Scholar : PubMed/NCBI
11	Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F and Hwang PM: P53 regulates mitochondrial respiration. Science. 312:1650–1653. 2006. View Article : Google Scholar : PubMed/NCBI
12	Nakamura H, Matoba S, Iwai-Kanai E, Kimata M, Hoshino A, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M, Mita Y, et al: P53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation. Circ Heart Fail. 5:106–115. 2012. View Article : Google Scholar
13	Rodriguez R and Meuth M: Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol Biol Cell. 17:402–412. 2006. View Article : Google Scholar :
14	Nishioka S, Nakano D, Kitada K, Sofue T, Ohsaki H, Moriwaki K, Hara T, Ohmori K, Kohno M and Nishiyama A: The cyclin-dependent kinase inhibitor p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia/reperfusion injury in mice. Kidney Int. 85:871–879. 2014. View Article : Google Scholar
15	Yang XL, Ma HX, Yang ZB, Liu AJ, Luo NF, Zhang WS, Wang L, Jiang XH, Li J and Liu J: Comparison of minimum alveolar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs. Anesthesiology. 104:482–487. 2006. View Article : Google Scholar : PubMed/NCBI
16	Zhou JX, Luo NF, Liang XM and Liu J: The efficacy and safety of intravenous emulsified isoflurane in rats. Anesth Analg. 102:129–134. 2006. View Article : Google Scholar
17	Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY and Chen CJ: Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinasesand AKT. Eur J Pharmacol. 563:49–60. 2007. View Article : Google Scholar : PubMed/NCBI
18	Chehrehasa F, Meedeniya AC, Dwyer P, Abrahamsen G and Mackay-Sim A: EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J Neurosci Methods. 177:122–130. 2009. View Article : Google Scholar
19	Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, et al: Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet. 23:333–337. 1999. View Article : Google Scholar : PubMed/NCBI
20	Leary SC, Cobine PA, Kaufm an BA, Guercin GH, Mattman A, Palaty J, Lockitch G, Winge DR, Rustin P, Horvath R and Shoubridge EA: The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis. Cell Metab. 5:9–20. 2007. View Article : Google Scholar
21	Hato S, Urakami A, Yamano T, Uemura T, Ota T, Hirai R and Shimizu N: Attenuation of liver and lung injury after hepatic ischemia and reperfusion by a cytokine-suppressive agent, FR167653. Eur Surg Res. 33:202–209. 2001. View Article : Google Scholar : PubMed/NCBI
22	Okaya T, Holthaus R, Kato A and Lentsch AB: Involvement of the neuropeptide substance P in lung inflammation induced by hepatic ischemia/reperfusion. Inflamm Res. 53:257–261. 2004. View Article : Google Scholar : PubMed/NCBI
23	Wang Z, Lv H, Song S, Shen X, Yang L and Yu W: Emulsified isoflurane preconditioning protects isolated rat Kupffer cells against hypoxia/reoxygenation-induced injury. Int J Med Sci. 10:286–291. 2013. View Article : Google Scholar : PubMed/NCBI
24	Qin Z, Lv E, Zhan L, Xing X, Jiang J and Zhang M: Intravenous pretreatment with emulsified isoflurane preconditioning protects kidneys against ischemia/reperfusion injury in rats. BMC Anesthesiol. 14:282014. View Article : Google Scholar : PubMed/NCBI
25	Kowaltowski AJ and Vercesi AE: Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med. 26:463–471. 1999. View Article : Google Scholar : PubMed/NCBI
26	Robin E, Guzy RD, Loor G, Iwase H, Waypa GB, Marks JD, Hoek TL and Schumacker PT: Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem. 282:19133–19143. 2007. View Article : Google Scholar : PubMed/NCBI
27	Zweier JL, Flaherty JT and Weisfeldt ML: Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 84:1404–1407. 1987. View Article : Google Scholar : PubMed/NCBI
28	Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC and Chua BH: Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol. 30:2281–2289. 1998. View Article : Google Scholar